Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: A randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa
European Journal of Cancer2005Vol. 41(8), pp. 1140–1149
Citations Over TimeTop 10% of 2005 papers
John A. Glaspy, David H. Henry, Ravi Patel, Simon Tchekmedyian, Steve Applebaum, Donald H. Berdeaux, Richard Lloyd, R. Berg, Matt Austin, Greg Rossi
Related Papers
- → The Impact of Methodological Approach on Cost Findings in Comparison of Epoetin Alfa with Darbepoetin Alfa(2009)16 cited
- → ERYTHROPOIETIN IN PREMATURE INFANTS(1982)3 cited
- → Cross-reactivity of epoetin alfa and darbepoetin alfa with two immunochemiluminometric erythropoietin assays(2007)1 cited
- → PCN5 COMPARING THE COST-EFFECTIVENESS OF FRONT-LOADED DARBEPOETIN ALFA WITH EPOETIN ALFA FOR ANEMIA MANAGEMENT IN CHEMOTHERAPY-TREATED CANCER PATIENTS IN UNITED STATES(2002)
- → Conversion from Epoetin Alfa to Darbepoetin Alfa in Hemodialysis Patients: Effectiveness and Variability in Anemia Treatment(2020)